Biomarkers and Predictive Factors for Treatment Response to Tumor Necrosis Factor-α Inhibitors in Patients with Psoriasis by Teppei Hagino, Hidehisa Saeki, Naoko Kanda

Get full text

The differential effects of upadacitinib treatment on skin rashes of four anatomical sites in patients with atopic dermatitis by Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Get full text

The Eosinophil-to-Lymphocyte Ratio Acts as an Indicator for Improvement of Clinical Signs and Itch by Upadacitinib Treatment in Atopic Dermatitis by Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Get full text

Effectiveness and safety of deucravacitinib treatment for moderate-to-severe psoriasis in real-world clinical practice in Japan by Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Get full text

Effects of Biologic Therapy on Laboratory Indicators of Cardiometabolic Diseases in Patients with Psoriasis by Teppei Hagino, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Get full text

Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan by Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Get full text

Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis by Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Get full text

Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis by Teppei Hagino, Mai Yoshida, Risa Hamada, Hidehisa Saeki, Eita Fujimoto, Naoko Kanda

Get full text